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List of Abbreviations  
 
4T1   A murine mammary epithelial tumor cell line 
ANO  Anoctamin 
ATP  Adenosine Triphosphate 
BEST  Bestrophin 
BLAST  Basic Local Alignment Search Tool 
CaCC  Calcium-activated Chloride Currents 
CaMKII Calmodulin-dependent protein Kinase II 
cAMP  Cyclic Adenosine Monophosphate 
cDNA  Complementary Deoxyribonucleic Acid 
CF  Cystic Fibrosis 
CFTR  Cystic Fibrosis Transmembrane conductance Regulator 
cGMP  Cyclic Guanosine Monophosphate 
CLC  Chloride Channel  
CLCA  Chloride channel, Calcium-activated 
CPAE   Calf Pulmonary Artery Endothelial cells 
DIDS  4,4’ diisothiocyanatostilbene-2,2’-disulfonic acid 
DNA   Deoxyribonucleic Acid 
EF1a  Elongation Factor 1!  
ENaC  Epithelial Sodium (Na) Channel 
et al.  et alii (latin for “and others”) 
GOI  Gene(s) Of Interest 
HC11   A clonal mammary epithelial cell line 
HEK293  Human Embryonic Kidney 293 cells 
IFRD1  Interferon-Related Developmental Regulator 1 
IL-4  Interleukin-4 
LCM  Laser Capture Microdissection 
miRNA  Micro Ribonucleic Acid 
mRNA  Messenger Ribonucleic Acid 
PCR  Polymerase Chain Reaction 
RNA  Ribonucleic Acid 
RT-qPCR Reverse Transcriptase quantitative Polymerase Chain Reaction 
siRNA  small interfering RNA 
SLC26A9 Solute Carrier Family 26, Member 9 
STAS  Sulfate Transporters and Anti-sigma-factor 
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TGFB1 Transforming Growth Factor Beta 1 
TMEM16 Transmembrane Protein 16 
TTYH  Tweety Homolog 
UV-A  UltraViolet A, long wave (400 nm-320 nm), or black light 
VRAC  Volume Regulated Anion Channel 
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1. Introduction 
 
1.1 Cystic Fibrosis 
1.1.1 Disease and Pathogenesis 
Cystic Fibrosis (CF), also called mucoviscidosis, is an autosomal recessive inherited 
disorder caused by mutations in the gene named cystic fibrosis transmembrane 
conductance regulator (CFTR; Ratjen and Doring 2003). It is a fatal genetic disease 
affecting primarily the Caucasian population. Approximately one in 25 Europeans 
(4%) carry one mutant CFTR allele and approximately one in every 3,000 newborn 
Europeans and Americans (0.03%) is affected, making it the most common fatal 
genetic disorder in these populations (Jonsdottir et al. 2008; Pearson 2009). The 
incidence is less frequent in African-Americans (1:17,000) and Asian populations 
(<1:100,000; McIntosh and Cutting 1992).  
The CFTR protein belongs to a family of ATP (adenosine triphosphate)-binding 
proteins encoded on chromosome 7. It encodes for a cAMP (cyclic adenosine 
monophosphate)-activated Cl- channel. More than 1,500 mutations of CFTR are 
known so far (Jonsdottir et al. 2008). The mutations can be grouped into six classes: 
(1) CFTR protein is premature and truncated; (2) defective processing and trafficking; 
(3) defective regulation; (4) defective conductance; (5) partly defective production or 
processing; and (6) defective regulation of other channels (Buchanan et al. 2009; 
Ratjen and Doring 2003). The most frequent mutation affecting approximately 70% of 
patients belongs to class two and is named "F508 due to a phenylalanine deletion at 
position 508 (Buchanan et al. 2009; Ratjen and Doring 2003).  
The disease presents as a multiple exocrinopathy based on defective Cl- secretion 
and hyperactivated sodium absorption in several exocrine epithelia like airways, 
pancreas, intestine, liver, vas deferens and sweat glands (McIntosh and Cutting 
1992; Schwiebert et al. 1998). Above all, cystic fibrosis causes severe pulmonary 
disease in infants and young adults, limiting life expectancy. The altered ion 
conductances result in lack of fluid secretion and thus development of stringy 
mucous. The pulmonary disease is characterized by mucous plugging, decreased 
mucociliary clearance, secondary bacterial infection especially by Pseudomonas 
aeruginosa, Staphylococcus aureus, Burkholderia cepacia (Drumm 2001), and 
fibrosis. Further frequent complications are pancreatic enzyme insufficiency, 
constipation, biliary cirrhosis, and infertility in males (>95%) due to obstruction or 
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absence of the vas deferens (Rowntree and Harris 2003). 15 % of CF patients are 
affected by meconium ileus at birth, a complication with high mortality (Zielenski et al. 
1999). 
 
1.1.2 Heterogeneity of Phenotype and Modulation of Disease Severity by 
Modifier Genes 
The cystic fibrosis phenotype shows large variations between affected individuals. 
These can partly be explained by the diversity of CFTR gene mutations. However, 
patients with the same CFTR genotype and even siblings or twins sharing most 
environmental factors show clinical variations (Kerem et al. 1990). This suggests that 
the CF phenotype is modulated by other genetic and environmental factors 
(Rozmahel et al. 1996; Santis et al. 1990).  
Several studies imply that genes (modifier genes) other than CFTR can significantly 
modify the CF manifestation of the basic defect and the clinical picture (Bronsveld et 
al. 2001). Genetic variations of alleles outside the CFTR locus may even influence 
disease outcome. Although these allelic variations may themselves fail to present an 
apparent affect in a healthy person, they could act as a modifier when accompanied 
by a mono-genetic disorder such as CF (Bremer et al. 2008; Cutting 2005; Drumm 
2001).  
 
1.1.3 CaCC as Modifiers in Cystic Fibrosis 
Several groups have demonstrated strong evidence that a Ca2+-activated Cl- 
conductance ameliorates disease severity in the intestine (Gray et al. 1994; 
Rozmahel et al. 1996), lung (Clarke et al. 1994; Grubb et al. 1994) and pancreas 
(Clarke et al. 1994). It may present a potential target for CF disease intervention but 
its molecular identity is unknown. Moreover, in cftr-/- mouse models Ca2+-activated 
Cl- currents (CaCC) have been detected in airways and pancreas (Clarke et al. 1994) 
as well as intestinal tissue of cftr-/- mice with prolonged survival (Rozmahel et al. 
1996). This CFTR-independent Cl- conductance has been observed in roughly 20% 
of CF patients homozygous for "F508 mutation on rectal biopsies (Bronsveld et al. 
2000). In contrast to human CF patients, most cftr-/- mouse models do not acquire 
the characteristic pulmonary phenotype but develop severe intestinal obstruction 
(Ratcliff et al. 1993). Clarke and coworkers therefore proposed that the Ca2+-
activated Cl- conductance observed in the airways could compensate for the lack of 
CFTR Cl- channel function. On the other hand, its absence from the intestine could 
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explain the severe pathology in this tissue (Clarke et al. 1994). Wilschanski and 
coworkers further found a Ca2+-activated Cl- conductance in the intestine of Class III 
Cftrm1HSC/m1HSC mouse models, characterized by prolonged survival, which again 
could be linked to the milder intestinal phenotype (Wilschanski et al. 1996). 
 
Ca2+-activated Cl- channels are one of five subgroups of anion channels found in 
excitable and non-excitable cells and may account for these currents. Their 
biophysiological characteristics have been analyzed in some detail, however, their 
molecular identity remains unknown. Ca2+-activated Cl- channels are activated by an 
increase in cytosolic Ca2+: (1) Some are activated directly by micromolar or 
submicromolar Ca2+ concentrations and direct Ca2+ binding; (2) others are activated 
indirectly by calmodulin-dependent protein kinase II (CaMKII) protein 
phosphorylation; and (3) others are activated by Ca2+ through cGMP (cyclic 
guanosine monophosphate)-activated channels (Hartzell et al. 2005; Jentsch et al. 
2002; Pusch 2004). Dependent on their single channel conductance they are 
grouped into (1) low (1-3pS); (2) intermediate (8pS and 15pS); and (3) higher (40-
50pS) conductance channels (Eggermont 2004; Gruber et al. 2000; Kuruma and 
Hartzell 2000). Ca2+-activated Cl- channels are time and voltage dependent whereby 
activation is voltage independent and inactivation is voltage dependent. Furthermore, 
they have a characteristic anion selective permeability sequence and they are 
sensitive to 4,4’ diisothiocyanatostilbene-2,2’-disulfonic acid (DIDS) and niflumic acid 
(Eggermont 2004; Gruber et al. 2000; Kuruma and Hartzell 2000). 
 
1.2 Candidate CaCCs and a Chloride Channel as Mediators of Alternative 
 Chloride Conductance  
CaCC are present in numerous cells, however, the molecular identity responsible for 
these currents is not well understood (Eggermont 2004).  
 
A number of genes encoding for Ca2+-activated Cl- channels or Ca2+-activated 
transporter proteins as well as mediators of Ca2+-activated Cl- currents with similar 
electrophysiological properties have been discovered, some of which are better 
characterized than others. These all could account for the observed alternative Cl- 
currents described in several secretory epithelia affected by CF.  
Candidates forming putative Ca2+-activated Cl- channels or transporters are 
bestrophins, CLC (chloride channels), tweety and TMEM16 (transmembrane protein 
16), also known as anoctamins. Candidate Ca2+-activated Cl- current mediating 
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proteins include a gene family named Cl- channels, calcium-activated, short CLCA 
(Gruber et al. 2002). Unlike CaCC, SLC26A9 (solute carrier family 26, member 9) is 
a Cl- channel inhibited by Ca2+ (Loriol et al. 2008). However, its association with 
CFTR and transepithelial Cl- channel activity could also make it an interesting target 
as alternative Cl- channel (Loriol et al. 2008). 
 
1.2.1 Bestrophins 
The family of bestrophins comprises four members in humans and three functional 
genes in mice (Barro Soria et al. 2006; Kramer et al. 2004). They function both as Cl- 
channels and as regulators of voltage-gated Ca2+ channels (Hartzell et al. 2008). In 
humans, several mutations in hBEST1 have been linked to the disease Best 
Vitelliform Macular Dystrophy (Hartzell et al. 2008). Bestrophins are multimeric 
proteins of which two contradictory topology models exist describing six (Milenkovic 
et al. 2007) or four (Tsunenari et al. 2003) transmembrane domains respectively.  
Bestrophins are directly activated by physiological concentrations of intracellular Ca2+ 
(Abdel-Ghany et al. 2003; Barro-Soria et al. 2009) and they are sensitive to DIDS 
and niflumic acid (Kunzelmann et al. 2007). Thus they show characteristic 
electrophysiological properties of CaCC. In particular the two murine family members 
mBEST1 and mBEST2 are interesting potential modifiers of CF disease severity as 
both account for Ca2+-dependent Cl- currents in mouse respiratory epithelium (Barro-
Soria et al. 2008). Furthermore, the mRNA (messenger ribonucleic acid) of murine 
mbest1 and BEST2, the human ortholog of mbest2, are expressed in the CF relevant 




Cl- Channels (CLC) are a family of nine Ca2+-activated and voltage gated Cl- 
transport proteins subdivided into two groups. Four CLC proteins (CLC-1, -2, -Ka, 
and -Kb) are voltage gated Cl- anion channels found at the plasma membrane and 
five (CLC-3 to -7) are Cl--H+ exchangers found on intracellular membranes (Devuyst 
and Guggino 2002; Duran et al. 2009). They are predicted to have 10-12 
transmembrane domains and the functional unit consists of a homodimer (Duran et 
al. 2009; Jentsch et al. 1999). Their channel structure model is based on 
crystallization data, reviewed in (Nilius and Droogmans 2003).  
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CLC proteins have been linked to several inherited diseases including Myotonia 
Congenita (CLC-1), Bartter’s Syndrome (CLC-Kb) and Dent’s Disease (CLC-5), 
reviewed in (Jentsch et al. 2002). CLC-2 and CLC-4 have both been discussed as 
candidates for alternative Cl- conductance in the absence of functional CFTR (Fuller 
and Benos 2000a; Mohammad-Panah et al. 2002; Nilius and Droogmans 2003).  
However, for CLC-2 in mice Zdebik and coworkers recognized that mice with 
disrupted cftr gene survived longer when the clc-2 gene was additionally disrupted 
(Zdebik et al. 2004). In mice, clc-2 was therefore concluded unlikely to be a key 
modifier gene in the lung and intestine (Blaisdell et al. 2004; Zdebik et al. 2004).  
CLC-4 on the other hand was found on human chromosome 19q13, a region 
containing putative modifier genes for CF (Gyomorey et al. 2001), which makes it an 
interesting candidate. Murine clc-4 has a broad tissue expression pattern including 
tissues relevant to CF like airways and intestine (Gyomorey et al. 2001; Mohammad-
Panah et al. 2002; Murray et al. 1995; Wang and Weinman 2004). Both its 
electrophysiological properties as a CaCC and its expression in CF relevant tissues 
make CLC-4 a putative alternative Cl- conductance pathway. 
The splice variant of human CLC-3, CLC-3B, co-localizes with CFTR-interacting PDZ 
proteins in the Golgi. Both CLC-3B and CFTR also bind ERM-binding 
phosphoprotein 50 and PDZK1, which are localized at the plasma membrane 
(Gentzsch et al. 2003). Little is known about CLC-3 and many laboratories had 
difficulties to measure CLC-3 currents (Jentsch et al. 1999). Due to a potential link 
between CLC-3B and CF due to its colocalization with CFTR, its murine ortholog was 
included in the studies. 
 
1.2.3 Tweety 
Of the three human homologs of tweety, hTTYH1 to -3, hTTYH3 resembles a 
promising modifier gene for CF because it encodes for a large conductance Ca2+ 
activated and DIDS-sensitive Cl- channel with five to six transmembrane segments 
(Suzuki 2006; Suzuki and Mizuno 2004). It is expressed in excitable tissues including 
the colon and kidney. Its murine ortholog mTTYH3 has additionally been located in 
the pancreas. Human hTTYH1 and hTTYH2 on the other hand are primarily 
expressed in the brain and hTTYH1 is a Ca2+-independent volume sensitive Cl- 
channel (Rae et al. 2001; Suzuki 2006; Suzuki and Mizuno 2004). Thus, hTTYH1 
and hTTYH2 are unlikely candidate modifier genes. Its localization in the CF relevant 






TMEM16 have recently been discovered as Ca2+-activated Cl- channels or CaCC 
subunits (Caputo et al. 2008; Schroeder et al. 2008; Yang et al. 2008).  Hydropathy 
analyses predicted eight putative transmembrane domains. Electrophysiological 
analyses suggested typical anionic channel properties, which led to them also being 
called anoctamins (Yang et al. 2008). There are 10 family members known to date. 
TMEM16A (ANO1) and TMEM16B (ANO2) were shown to generate voltage 
dependent Cl- currents activated by physiological Ca2+ signals in multiple expression 
systems including Axolotl oocytes and mammalian HEK293 (human embryonic 
kidney 293 cells) cells (Caputo et al. 2008; Duran et al. 2009; Hartzell et al. 2009; 
Schroeder et al. 2008; Yang et al. 2008). Murine mTMEM16A is expressed in various 
secretory epithelia including tissues relevant to CF such as pancreas, colon, liver, 
lungs, kidneys and stomach (Caputo et al. 2008; Rock et al. 2009; Schroeder et al. 
2008; Yang et al. 2008). TMEM16F (ANO6) and TMEM16K (ANO10) are of special 
interest in the respiratory tract where they were shown to be expressed in tracheal 
epithelium and mesenchyme and display candidates for residual CaCC in 
tmem16a-/- mice (Rock et al. 2009). Its electrophysiological properties and 
expression pattern make mtmem16a a likely candidate modifier gene and alternative 
target in CF (Yang et al. 2008). 
 
1.2.5 SLC26A 
Although it does not evoke a characteristic CaCC, SLC26A was included in the 
studies. The SLC26 transporters consist of 11 family members known to date. Based 
on functional similarities some can be grouped into three groups: Group (1) are 
sulfate transporters including SLC26A1 and SCL26A2; Group (2) are Cl-/HCO3
- 
exchangers including SLC26A3, SLC26A4 and SLC26A6; Group (3) are selective Cl- 
channels including SLC26A7 and SLC26A9, reviewed in (Dorwart et al. 2008).  
Several family members have been associated with genetic disease: SLC26A2 with 
chondrodysplasias; SLC26A3 with Cl--losing diarrhea; SLC26A4 in Pendred 
syndrome and hereditary deafness (Mount and Romero 2004). 
Membrane-spanning prediction algorithms predicted between eight and 14 
transmembrane segments (Bertrand et al. 2009). An important structural component 
seems to be the STAS (sulfate transporters and anti-sigma-factor) domain, a protein-
protein interaction domain involved in transport function (Bertrand et al. 2009).  
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In both human and murine SLC26A3 and SLC26A6 the STAS domains interact with 
CFTR R-domains. However, when expressed in HEK293 cells these two family 
members did not generate measurable Cl- currents (Bertrand et al. 2009).  
SLC26A9 is also associated with CFTR and contributes significantly to anion 
secretion in airway gland and surface epithelia (Bertrand et al. 2009). Interaction with 
CFTR regulates epithelial fluid and electrolyte secretion and thus modulated the 
airway surface liquid volume (Bertrand et al. 2009), reviewed in (Dorwart et al. 2008). 
Electrophysiologically the Cl- channel SLC26A9 was inhibited by DIDS and is 
insensitive to intracellular cAMP. Ca2+ also inhibited SLC26A9 associated currents 
(Loriol et al. 2008). 
Human SLC26A family members are found in all of the epithelia where CFTR has 
been found (Bertrand et al. 2009). Of these, SLC26A9 is predominantly expressed in 
the lung where it is found in the luminal membrane of ciliated airway bronchial and 
alveolar epithelial cells, gastric surface and lesser in glandular cells, reviewed in 
(Dorwart et al. 2008). 
SLC26A9 does not outline a Ca2+-activated Cl- channel. However, its contribution to 
transepithelial Cl- channel activity in bronchial epithelia and its association with CFTR 
could make it an interesting target as alternative Cl- channel (Loriol et al. 2008). 
1.2.6 CLCA 
The CLCA gene family encodes a class of proteins, some of which mediate a Ca2+-
activated Cl- conductance sensitive to DIDS when expressed in Xenopus oocytes or 
HEK293 cells (Fuller and Benos 2000b; Gruber et al. 2000).  Since their discovery in 
the early 1990ies (Cunningham et al. 1995; Ran and Benos 1992, 1991; Zhu et al. 
1991), 42 family members have been identified in altogether 11 mammalian species 
(Plog et al. 2009). Human and murine members are located on human chromosome 
1p and murine chromosome 3, respectively (Ritzka et al. 2004).  
In the nomenclature the species is indicated by h (human), m (murine), p (porcine), b 
(bovine), e (equine) and so forth. The homologs within a species are numbered in 
order of their discovery (Gruber et al. 2002).  
A number of CLCA gene family members have been partially characterized including 
the four human homologs hCLCA1 to -4 (Agnel et al. 1999; Gruber et al. 1998a; 
Gruber and Pauli 1999) and the six murine homologs mCLCA1 (Gandhi et al. 1998; 
Romio et al. 1999), mCLCA2 (Lee et al. 1999), mCLCA3 (Komiya et al. 1999; 
Leverkoehne and Gruber 2002), mCLCA4 (Elble et al. 2002), mCLCA5 (Braun et al. 
2009; Evans et al. 2004) and mCLCA6 (Bothe et al. 2008; Evans et al. 2004). 
Although they show high interspecies sequence homologies on mRNA (Figure 1) and 
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protein levels they are characterized by a heterogeneous, species and cell-specific 
expression pattern for each family member (Gruber et al. 2000; Pauli et al. 2000).  
Despite their name, biochemical and electrophysiological data suggest that some 
CLCA proteins may not represent channel proteins of their own but are more likely to 
function as extracellular signaling molecules and regulate other, yet unknown 
channels (Gibson et al. 2005; Mundhenk et al. 2006; Plog et al. 2009). Human 
hCLCA1 for example influences conductance of Ca2+-dependent Cl- channels 
(Hamann et al. 2009). Based on biochemical characterizations CLCA proteins can be 
grouped into two existing models. One group, including hCLCA1, its murine ortholog 
mCLCA3 and its porcine ortholog pCLCA1 (Gibson et al. 2005; Mundhenk et al. 
2006; Plog et al. 2009), form heterodimeric glycoproteins that are fully secreted by 
the cell. The other group, including mCLCA6 (Bothe et al. 2008) and hCLCA2 (Elble 
et al. 2006) is anchored to the plasma membrane via a transmembrane domain.  
Although CLCA proteins have electrophysiological similarities to CaCC, in contrast to 
CaCC they have time independent currents and are activated by high, non-
physiological Ca2+ concentrations (Abdel-Ghany et al. 2003; Gandhi et al. 1998; 
Gruber et al. 1998a; Gruber and Pauli 1999). 
Like CFTR, the majority of family members known to date are predominantly 
expressed in secretory epithelial cells (Gruber et al. 1998a). Of the murine family 
members the cellular localizations of mCLCA1 and mCLCA2 were previously 
narrowed down by in situ hybridization to intestinal epithelial cells of the crypts, 
respiratory epithelial cells, gall bladder epithelium, acinar glands of the pancreas, 
squamous epithelia and germinal centers of lymphoid tissues (Gruber et al. 1998a; 
Leverkoehne et al. 2002). Due to their high sequence identities, this expression 
pattern resembled an overlap between both family members. The cellular expression 
patterns were further determined in the Group of Frank Thevenod in cooperation with 
Gruber and coworkers (Roussa et al. 2010). They found mCLCA1 and -2 mRNA and 
protein in parotid and submandibular glands. Immunolabeling further revealed both to 
be present in small intestinal crypt enterocytes. The mCLCA3 protein was identified 
in goblet cells and other mucin-producing cells of various tissues including the 
respiratory and gastrointestinal tracts (Leverkoehne and Gruber 2002) using 
immunohistochemistry and immune electron microscopy. For mCLCA4, in situ 
hybridization revealed expression in smooth muscle cells of various organs including 
intestine and stomach as well as in the mucosa of the gastrointestinal tract (Elble et 
al. 2002). The cellular localization of the two most recently discovered murine CLCA 
family members mCLCA6 and mCLCA5 (Evans et al. 2004) are still unknown. 
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A number of functions including opposing results concerning their possible 
modulatory role in CF have been discussed between humans and mice (Abdel-
Ghany et al. 2003; Fuller and Benos 2000a; Gruber et al. 2000; Pauli et al. 2000). 
Bronsveld and coworkers showed that in contrast to CFTR-/- mouse models (Clarke 
et al. 1994; Rozmahel et al. 1996) the Ca2+-dependent Cl- secretion in respiratory 
tissue showed no association with disease outcome in human patients (Bronsveld et 
al. 2001). Ritzka and coworkers found a strong correlation between allelic variants at 
the human CLCA gene locus hCLCA1 or, less likely, hCLCA4 and CFTR-
independent Cl- conductance in section biopsies of CF patients (Ritzka et al. 2004). 
Interestingly, the number of patients developing intestinal complications is less 
frequent than in mice (Cutting 2005). 
Despite different hypotheses, their electrophysiological properties, which are similar 
to those of CaCC make all mCLCA potential candidate mediators for alternative Cl- 
conductance. Additionally, their expression in CF relevant tissues supports relevance 
in CF. However, the cellular expression of the two most recently discovered murine 
family members mCLCA5 and mCLCA6 are still unknown.  
 
Figure 1:  
Phylogenetic Tree of Murine and Human CLCA mRNA Nucleotide Sequence Identities 
Phylogenetic tree of the murine and human CLCA gene family members according to their mRNA nucleotide 
sequence identities. Sequence alignment and calculation of the phylogenetic tree were carried out with the ClustalV-






1.3 Mouse Models and Strains 
To study the individual candidates for alternative Cl- conductance the mouse was 
chosen as model species. Subsequently to the cloning of the CFTR gene in 1989, 
several mouse models of CF were generated by gene-targeting approaches. All 27 
exons of the murine cftr are very similar to those of the human CFTR and the 
proteins show 78 % similarity (Ellsworth et al. 2000; Kukavica-Ibrulj and Levesque 
2008). In 1992 the first mouse model was generated (Snouwaert et al. 1992). To 
date 11 mouse models have been developed which can be categorized into (1) CF 
mice with residual CF function; (2) cftr knockout mice with complete loss of function; 
and (3) mice with specific cftr mutations frequently observed in humans including 
"F508  (Scholte et al. 2004), G551D (Delaney et al. 1996) and G480C (Davidson 
and Rolfe 2001; Dickinson et al. 2000; Grubb and Gabriel 1997; Kukavica-Ibrulj and 
Levesque 2008). 
Of the two CF mouse models used in this study one, cftrTgH(neoim)Hgu, represents a 
mutation with residual cftr function (Dorin et al. 1992) and one, cftrtm1Cam, represents 
a complete knockout (Ratcliff et al. 1993).  
 
The following paragraphs give an outline about the important features concerning the 
two mouse models used in this study.  
 
The cftrTgH(neoim)Hgu mouse model was previously created by others by disrupting exon 
10 of the cftr gene in embryonic stem cells using an insertional gene targeting vector 
(Dorin et al. 1992). Exon skipping and aberrant splicing allowed low levels of residual 
wild-type cftr mRNA to still be produced. 10% were still produced in the lungs and 
20% in the intestine. Disease severity was thereby ameliorated in comparison to 
complete knockout mice (Dorin et al. 1994).  
Similar to CF, especially to CF patients with "F508 mutation (Bronsveld et al. 2000), 
the mutant mice demonstrated a reduced cAMP-induced Cl- secretion typically 
evoked by CFTR both in the intestinal and respiratory tracts in vivo and in vitro 
(Smith et al. 1995). The mice also showed an increased negative nasal potential 
difference which could be related to an increased Na+ absorption, again typical for 
CF (Smith et al. 1995). A Ca2+ related Cl- secretion was reduced in the intestine and 
preserved in the respiratory tract. 
Histopathological changes were also consistent with those seen in CF. The colon 
was only mildly dilated with increased mucus accumulation. Thus, cftrTgH(neoim)Hgu mice 
resemble the human intestinal CF phenotype more strongly than other mouse 
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models (Dorin et al. 1994). Pancreas and lungs were predominantly without 
pathological finding (Dorin et al. 1992). 
 
The cftrtm1Cam mouse model mimics a complete functional knockout. A termination 
codon was previously introduced into the coding sequence of the murine cftr gene 
and caused a disruption of the cftr locus (Ratcliff et al. 1993). Homozygous pups 
failed to thrive and approximately 80% died in the first few days of life due to 
meconium ileus. Mice that survived the peripartal period suffered from intestinal 
obstructions. Interestingly, only about 15% of CF patients suffer meconium ileus. 
Electrophysiologically, these mice lacked a cAMP-activated Cl- conductance in 
tracheal and caecal measurements. In contrast to human airway epithelium, an 
increased Na+ absorption was not observed in the murine trachea. They did, 
however, have a Ca2+-dependent Cl- secretion in airway epithelial cells. 
In the pathohistological examinations the intestine showed dilation of the small 
intestinal crypts and accumulation of mucus. The pancreas showed dilation and 
blockage of the small pancreatic ducts in half of the examined animals older than 17 
days. The lungs were without pathological finding (Ratcliff et al. 1993). 
Both mouse models therefore mimic several important electrophysiological and 
histological aspects of the human CF disorder making them suitable models routinely 
used to study the pathology of CF.  
 
Despite striking similarities between human CF and the effect of the cftr mutation on 
mice, the dissimilarities between both species need to be considered when projecting 
back to the human. Important differences between CF models and human CF 
patients are observed in pancreatic function and the pulmonary phenotype (Davidson 
and Rolfe 2001). Pancreatic insufficiency is a hallmark of most CF patients but 
mouse models fail to develop this manifestation. Similarly, pulmonary disease is 
cause of most morbidity and mortality in CF patients but mouse models do not share 
this phenotype. This may indicate alternative fluid secretory pathways, possibly 
CaCC, present in both organ systems ( Clarke et al. 1994; Gray et al. 1995; Grubb 
and Gabriel 1997).  
Anatomical differences between the lungs of mice and humans has led to doubt 
whether a cftr-mutant mouse could mimic the human CF lung disease (Collins 1992). 
In humans, lung disease gradually develops over years following repeated 
exacerbations of pulmonary infections with typical bacterial pathogens. Pulmonary 
disease is only poorly correlated with the CFTR genotype (Cutting 2005) and the 
predominantly neutrophilic inflammatory response is only poorly correlated to the 
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amount of infectious stimuli (Muhlebach and Noah 2002). In contrast to humans, 
however, mouse models for research purposes are generally kept in SPF facilities 
and killed at the age of 10 weeks. Furthermore, despite lack of spontaneous lung 
disease, when challenged with bacterial pathogens, CF mice lack physiological 
clearance and develop marked inflammation (Davidson et al. 1995).  
Differences in severity between the human CF and the mouse phenotype resembling 
CF may also be due to different levels of mRNA expression and genetic background 
of the mouse strain. The genetic background may correlate to varying activity of 
modifier genes (Kukavica-Ibrulj and Levesque 2008). Therefore we chose different 
genetic backgrounds for our studies. The following backgrounds were chosen, 
partially based on access and availability: C57BL/6, NMRI, BALB/c, DBA/2, the first 
three of which were used for publication. 
 
C57BL/6 wild type mice were used for expression analyses for the purpose of better 
comparison with previous expression analyses on the same background done for 
other murine CLCA family members (Gruber et al. 1998b; Leverkoehne and Gruber 
2002).  
The cftrtm1Cam mouse model had been generated, by others on a NMRI background to 
compensate for the high rate of early mortality. These mice have a longer survival 
rate when they additionally receive an oral laxative at weaning to prevent an 
intestinal ileus (Holle 2007). Again, the higher survival rate of the CF mutation in the 
NMRI strain suggests a strong influence of the genetic background on the 
development of the disease.  
The cftrTgH(neoim)Hgu mouse model had been generated by others on BALB/c, DBA/2 
and C57BL/6 backgrounds each. In BALB/c mice a significantly higher DIDS-
sensitive, Ca2+-activated Cl- conductance was noticed previously compared to DBA/2 
and C57BL/6 mice (Bleich et al. 2007). CF mice on a BALB/c background also 
exhibited the highest increase in Cl- current in response to carbachol and forskolin 
stimulation of the proximal colon (Bleich et al. 2007). In addition, it had been 
speculated that mCLCA3 expression is induced in BALB/c mice with lost CFTR 
function but not in C57BL/6 mice and might compensate function in the airways 





1.4 Aims and Hypotheses 
There were two primary aims and hypotheses: 
First aim was to investigate the tissue expression pattern and cellular localization of 
the two new murine CLCA family members mCLCA5, ortholog to human hCLCA2, 
and mCLCA6, ortholog to human hCLCA4. Knowledge of their cellular localization is 
an important prerequisite for future functional studies and to pinpoint their potential 
relevance in the complex of CF. The hypothesis was that these two CLCA family 
members would occupy cell type specific niches relevant to CF, similar as was 
demonstrated for mCLCA3. The mRNA of both family members was quantified in a 
broad spectrum of murine tissues using real-time reverse transcriptase quantitative 
polymerase chain reaction (RT-qPCR). Next, laser capture microdissection (LCM) of 
relevant tissues expressing the candidates was employed to narrow down their 
cellular localization. For mCLCA5 additional immune electron microscopical 
investigations were carried out to localize the protein on ultrastructural level. 
 
Second aim was to identify whether the CaCC candidates mCLCA1 to -6, mBEST1, 
mBEST2, mCLC-3B, mCLC-4, mTTYH3, mTMEM16A, mTMEM16F and 
mTMEM16K as well as the Cl- channel SLC26A9 may play a role in CF. In particular, 
the aim was to test the hypothesis that these proposed candidates with modulatory 
roles for anion conductance in CF are up-regulated on transcriptional level in CF 
versus normal tissues. To do so the altogether 15 candidate genes were quantified in 
CF relevant tissues on mRNA level to identify a molecule or regulatory pathway 
involved.  
Experiments were conducted in two CF mouse models: One with a mild intestinal 
phenotype (cftrTgH(neoim)Hgu) on BALB/c, DBA/2 and C57BL/6 genetic backgrounds and 
one with a severe intestinal phenotype (cftrtm1Cam) on a NMRI genetic background. 
Both animal models show classical phenotypical characteristics of CF including 
intestinal obstruction, severity dependent on genotype, goblet cell hyperplasia, 
mucus accumulation and crypt dilation, similar as seen in meconium ileus of human 
patients (Dorin et al. 1994; Ratcliff et al. 1993). They also have characteristic 
intestinal and airway electrophysiology including reduced or absent cAMP-induced 
Cl- conductance in epithelial cells of intestine and airways dependent on genotype 
(Dorin et al. 1994; Ratcliff et al. 1993). 
An up- or down-regulation of one or several of the candidate genes on transcriptional 
level could point towards a functional significance in the CF pathology and a potential 
target in CF therapy. Relative mRNA copy numbers were determined and compared 
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between the CF and respective wild type tissues. Copy numbers were also 
compared between both CF mouse models to help identify modulating factors and 
between the different wild type background strains to account for variable other 
genetic influences. 
 
Expression analyses carried out for mCLCA1, -2, -3, -4 and -6 on DBA/2 and 
C57BL/6 wild type strains and their CF-counterparts are included in the concluding 
discussion and depicted in the attachments. The CF mouse models and strains were 
used according to availability; we neither had the means to produce new mice of the 
same strains and models nor to breed new models. 
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With kind permission from Springer Science+Business Media: Histochemistry and 
Cell Biology, Murine mCLCA5 is expressed in granular layer keratinocytes of 
stratified epithelia, 133(3), 2009, 285-99, Josephine Braun, Melanie K. Bothe, Lars 
Mundhenk, Carol L. Beck, Achim D. Gruber, figure numbers 1 to 7, copyright 
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4. Concluding Discussion 
 
This study focused on identifying the cellular localization of the two recently 
discovered murine CLCA family members mCLCA5 and mCLCA6. It also contributed 
to evaluating whether the candidate CaCC mediators mCLCA1 to -6, mBEST1, 
mBEST2, mCLC-3B, mCLC-4, mTTYH3, mTMEM16A, mTMEM16F and 
mTMEM16K as well as SLC26A9 may be involved in CF disease severity based on 
differences in quantitative mRNA expression. 
 
4.1 Validation of Methods 
Reliability of the results is based on the validity of the methods used. An important 
part of this study was therefore adequate sample acquisition and adequate 
preparation of RNA to ensure optimal mRNA quality. Tissue samples were 
processed immediately after killing the mice and were snap-frozen in liquid nitrogen. 
All steps involving handling of RNA were carried out without time delay and on ice 
unless stated otherwise according to the manufacturers’ protocols. Roughly equal 
amounts of tissue samples were each sufficiently homogenized prior to nucleic acid 
extraction. Contamination with genomic DNA (deoxyribonucleic acid) was prevented 
by designing the primers to span an intron and treating the sample with DNase 
digestion. RNA templates were quality checked and quantified using the NanoDrop® 
ND-1000 Spectrophotometer. 
The expression patterns of both mCLCA5 and mCLCA6 were analyzed on cellular 
level. In order to distinguish between the levels of mRNA expression within the 
different cell types, these specific cell types were isolated and collected individually 
by laser capture microdissection (LCM). Here, a pulsed UV-A (ultraviolet A) laser 
was focused through the objective lens of the microscope and used to separate the 
cells in a photochemical process in a non-contact manner without heat transfer. The 
process is therefore contamination-free and mRNA is ideally not affected. The 
isolated cells are then catapulted into the collecting device by the laser, again in a 
non-contact process (Burgemeister 2005). 
Principle method used for evaluating the mRNA expression levels in various murine 
tissues and single cells both for expression analyses of mCLCA5 and mCLCA6 and 
for comparison of quantitative expression levels was a fluorescence-based real-time 
quantitative PCR. This method is the touchstone for nucleic acid quantification and 
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has the capacity to detect minimal amounts of specific nucleic acid sequences with a 
high degree of sensitivity, specificity and quantitative precision.  
In order to identify the mRNA expressing cell type specifically for mCLCA5 and 
mCLCA6 and in order to quantify the expression levels of the individual murine CLCA 
family members mCLCA1 to -6 the challenge in this study was to establish assays 
which could reliably distinguish between the closely related family members (Elble et 
al. 2002; Leverkoehne et al. 2002) which share nucleic acid sequence identity of up 
to 96% between mCLCA1 and mCLCA2 (Table 1).  
 
Table 1:  
Murine and Human CLCA Nucleic Acid Sequence Pair Distances 
Degree of nucleic acid sequence identities (top right) and divergences (bottom left) of the murine and human CLCA 
gene family members. Sequence alignment and calculation of pair distances was carried out with the ClustalV-
Method (MegAlign, Lasergene, DNAStar Inc. Madison, WI, USA) 
 
















































mCLCA1  96.0 47.3 75.9 42.3 45.8 45.6 42.5 68.4 48.5 
mCLCA2 3.3  47.7 71.4 38.8 46.1 43.7 40.3 62.8 46.4 
mCLCA3 59.1 60.2  43.9 35.0 50.4 71.0 37.4 43.1 53.6 
mCLCA4 18.2 21.5 58.5  39.1 42.8 38.5 41.0 61.6 44.4 
mCLCA5 69.1 73.0 75.3 71.8  34.3 36.8 65.6 36.5 33.7 
mCLCA6 59.3 60.8 54.4 62.2 78.9  53.5 38.5 45.2 69.0 
hCLCA1 55.9 58.3 26.5 56.1 76.5 50.5  36.8 44.3 57.9 
hCLCA2 62.6 67.6 75.8 68.5 30.5 76.3 74.0  40.0 38.8 














hCLCA4 56.8 59.1 49.6 60.7 78.2 29.4 40.6 71.5 57.4  
 
The primer and hydrolysis probe combinations used were either designed and 
purchased according to previous successful work of our team - for mCLCA1, 
mCLCA2, mCLCA4 (Leverkoehne et al. 2006; Leverkoehne et al. 2002); or newly 
designed and an assay established - for mCLCA3, mCLCA5, mCLCA6, mBEST1, 
mBEST2, mCLC-3B, mCLC-4, mTTYH3, mTMEM16A, mTMEM16F, mTMEM16K, 
SLC26A9. Assays were designed to run with an analytical sensitivity of measuring at 
least 102 mRNA copies of gene of interest accurately in the respective plasmid-cDNA 
(complementary deoxyribonucleic acid) or PCR-product cDNA. The analytical 
specificity was tested by several means. An in silico BLAST (basic local alignment 
search tool) search of the primers and probe combinations revealed 100% target 
specificity. Additionally, for the murine CLCA family members, cross-reactivity was 
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experimentally excluded for the mCLCA family members by following procedures: 
Amplification products were tested in conventional PCR showing specific sizes and 
only a single PCR product following agarose gel electrophoresis. Furthermore, DNA-
sequencing of the respective PCR-products of all analyzed genes verified the 
specificity of the assays.  
The PCR amplification efficiencies lay between 95% and 105% for all assays. 
Repeatability and reproducibility of the assays were further verified. Both intra-assay 
and inter-assay variance had a standard deviation of between 0 and 5% coinciding 
with the recommendations by Bustin (Bustin 2000). Based on these results a robust 
assay performance was assumed. 
The reference gene used for normalization was elongation factor 1! (EF1a). It is a 
universal cofactor in protein synthesis and is stably expressed in all living cells and 
tissue types (Gruber and Levine 1997) and was successfully used in several projects 
before (Leverkoehne et al. 2006; Leverkoehne et al. 2002). It was abundantly 
expressed in all tissue samples tested and correlated well with the total amount of 
RNA within each sample. Relative gene expressions were calculated as ratios 
representing the copy numbers of the gene of interest relative to the internal 
reference EF1a. 
 
4.2 Cellular Expression of mCLCA5 and mCLCA6 
The cellular localization of mCLCA3, the murine ortholog of hCLCA1, had been 
previously determined and those of mCLCA1, mCLCA2 and mCLCA4, the murine 
orthologs of the product of human pseudogene hCLCA3, were previously narrowed 
down: The mCLCA3 protein was identified in goblet cells and other mucin producing 
cells of various tissues including the respiratory and gastrointestinal tracts 
(Leverkoehne and Gruber 2002) using immunohistochemistry and immune electron 
microscopy. For mCLCA1 and mCLCA2 the quantitative mRNA tissue expression 
patterns were already established (Leverkoehne et al. 2002). Furthermore, their 
combined expression pattern was narrowed down by in situ hybridization to intestinal 
epithelial cells of the crypts, respiratory epithelial cells, gall bladder epithelium, acinar 
glands of the pancreas, squamous epithelia and germinal centers of lymphoid tissues 
(Gruber et al. 1998b). Due to their high sequence identities, this expression pattern 
resembled an overlap between both family members. The cellular expression 
patterns were further determined by the group of Frank Thevenod (Roussa et al. 
2010). They found mCLCA1 and -2 mRNA and protein in parotid and submandibular 
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glands. Immunolabeling further revealed both to be present in small intestinal crypt 
enterocytes. For mCLCA4, in situ hybridization with a mCLCA4 specific probe has 
revealed expression in smooth muscle cells of various organs including intestine and 
stomach as well as in the mucosa of the gastrointestinal tract (Elble et al. 2002). 
In this study the cellular localization of the two most recently discovered murine 
CLCA family members of were determined: mCLCA5, the murine ortholog of 
hCLCA2, and mCLCA6, the murine ortholog of hCLCA4. mCLCA5 and mCLCA6 
were first discovered in 2004 (Beckley et al. 2004; Evans et al. 2004) and cloned in 
the same year by the group of Evans (Evans et al. 2004). 
 
4.2.1 Cellular Expression of mCLCA5 
mCLCA5 mRNA had a broad expression pattern in virtually all tissues analyzed but 
was predominantly detected in keratinocytes of all stratified squamous epithelia that 
undergo cornification including squamous epithelium of the skin and nonglandular 
mucosa of the stomach. Subsequent immune electron microscopy specifically 
localized the mCLCA5 protein to cytoplasmic granules of granular layer keratinocytes 
and, to a lesser extent, to spinous and cornified layer keratinocytes. In tissues 
physiologically lacking keratinocytes expression of mCLCA5 mRNA was close to the 
lower detection limit. 
 
4.2.2 Cellular Expression of mCLCA6  
mCLCA6 showed quite a different expression pattern: mCLCA6 mRNA was 
exclusively detected in the intestinal tract of all tissues analyzed with an expression 
peak in the ileum. Along the crypt-villous axis the epithelial cells of the villous tips of 
the jejunum and the luminal epithelial cells of the caecum (Attachments: Figure 2) 
showed highest mRNA expression. In contrast to its human ortholog hCLCA4, it was 
not expressed in the brain or trachea (Agnel et al. 1999). 
Analyses defining the difference between the expression levels of both mCLCA6 and 
mCLCA3 between the luminally located and basally located epithelial cells of the 
caecum were additionally carried out. The mean relative mRNA copy numbers of 
mCLCA6 and mCLCA3 were approximately 40-fold and 5-fold higher in the luminal 
enterocytes, respectively. mCLCA6 had an approximately 8-fold higher relative 
expression in the luminally located enterocytes than mCLCA3. This is likely due to 
mCLCA6 being expressed in a more abundant type of epithelial cell than mCLCA3. 
In fact, these data can be backed up based on literature on protein level: Whereas 
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mCLCA3 is expressed in goblet cells (Leverkoehne and Gruber 2002) mCLCA6 is 
expressed in the more abundant non-goblet cell enterocytes (Bothe et al. 2008). 
Immunohistochemical staining results carried out at the same time in our research 
group corroborated these results in the jejunum on the protein level. In the colon the 
crypts showed predominant staining (Bothe et al. 2008).  
 
4.2.3 Do mCLCA5 and mCLCA6 Occupy Specific Functional Niches? 
The expression patterns of both mCLCA5 and mCLCA6 could confirm the notion that 
different CLCA family members allocate to different cellular locations. CLCA are 
widely distributed in mammalian tissues with a species-specific cellular expression 
pattern for each family member described so far (Bothe et al. 2008). The cellular 
expression patterns of both mCLCA5 and mCLCA6 complement and broaden this 
picture.  
This again could suggest that despite similar electrophysiological characteristics 
described in transfected cells, the protein products may have differing, cell specific 
functions or may even be multifunctional. 
For example, all murine CLCA mRNA discovered and analyzed to date are 
expressed in different histological units of the gastro-intestinal tract: mCLCA1 and 
mCLCA2 were found in the stomach and the crypt epithelial cells of the intestine 
(Gruber et al. 1998b). Due to their high sequence homology and lack of 
differentiation in in situ hybridization in the intestine the expression pattern 
represented the sum of both. mCLCA3 was immunolocalized to secretory granules of 
goblet cells in the intestinal tract as well as the respiratory and reproductive tracts 
(Leverkoehne and Gruber 2002). Its human ortholog hCLCA1 and its orthologs in 
other species, equine eCLCA1 (Anton et al. 2005) and porcine pCLCA1 (Plog et al. 
2009), all have an expression in goblet cells in common. mCLCA4 was located to 
smooth muscle cells (Elble et al. 2002) including those in the stomach and intestine. 
Here, mCLCA5 was predominantly expressed in the keratinocytes of the stomach. 
mCLCA6 on the other hand was found in the intestinal tract in the luminally located 
epithelial cells, a niche where no other CLCA family member has been described.  
Allocation of different murine CLCA family members to different cell types in the 
intestinal microenvironment supports the model of different evolutionary paths for 
each homolog and suggests the proteins filling different functional niches. 
The mRNA localizations of mCLCA5 and mCLCA6 could lead to subsequent 




LCM and immune electron microscopy located mCLCA5 to keratinocytes of the 
stratified epithelium of the stomach. Therefore, a role in cornification of stratified 
squamous epithelia is plausible. In stratified squamous epithelia proliferation takes 
place only in the basal layer, whereas the stratum spinosum and stratum granulosum 
display layers with primarily differentiating and not proliferating keratinocytes (Yuspa 
et al. 1988). Keratinocyte differentiation in cornifying epithelium, which is largely 
Ca2+-dependent (Yuspa et al. 1988) aims at developing the cornified envelope. In the 
pars nonglandularis of the stomach mCLCA5 protein was detected in keratinocytes in 
the granular layer, the layer that undergoes cornification. Again, the mRNA 
expression pattern and cellular localization could be backed by immunohistochemical 
staining results by our group (Braun et al. 2009). 
A further aspect to consider is that the keratinocytes of the supra-basal layers are 
non-proliferative. A proliferation inhibiting function has already been described for 
mCLCA5 in association with growth suppression of metastatic breast cancer cells 
(Beckley et al. 2004). In that study HC11 and 4T1 cells (murine mammary epithelial 
cell lines) showed decreased proliferation when transiently transfected with 
mCLCA5, suggesting a proliferation-inhibiting role of mCLCA5.  
Similar to mCLCA5, its human ortholog hCLCA2 was detected in the stratified 
epithelia of the cornea, skin, vagina, oesophagus and larynx with affinity-purified anti-
hCLCA2 antibodies and real-time PCR and not in non-stratified epithelia of the small 
intestine and human stomach (Connon et al. 2005; Connon et al. 2004; Gruber et al. 
1999). Unlike mCLCA5, hCLCA2 was localized to the basal cells adjacent to the 
basement membrane (Connon et al. 2004). The close apposition of hCLCA2 to 
hemidesmosomes led to the presumption of a role in epithelial stratification and 
particularly in adhesion mechanisms involving integrin-!4, a component of 
hemidesmosomes (Carter et al. 1990; Connon et al. 2004). A ligation between 
hCLCA2 and integrin-!4 is a feature of both quiescent stratified epithelia and 
metastatic cancer cells (Connon et al. 2005). The mCLCA5 protein is also reported to 
have a !4 binding domain (Abdel-Ghany et al. 2003) but was detected in the 
differentiated keratinocytes of the stratum granulosum of the stomach and not next to 
the basement membrane where hemidesmosomes are described (Braun et al. 2009).  
Surprisingly however, the mRNA expression pattern is broader than that described 
for the protein expression pattern which is limited to keratinocytes of all stratified 
epithelia (Braun et al. 2009). For example, only mCLCA5 mRNA could be detected in 
non-cornifying epithelia such as the cornea. This suggests that the mRNA may be 
transcribed into protein and suggests a role of the protein in the development of the 
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cornified envelope. Possibly mCLCA5 mRNA resides in all keratinocytes and the 
protein expression peaks during the process of cornification. 
The heterogeneous distribution of mCLCA5 mRNA could further support the 
implications that it is expressed in tissues that are growth-arrested or apoptotic or 
being involved in anoikis (Beckley et al. 2004; Patel et al. 2006). Maybe the protein is 
expressed at specific times in the cell cycle. Alternatively, presuming the protein is 
involved in cornifying processes of stratified epithelia, the mRNA may be translated 
into a protein in tissues undergoing metaplasia into stratified squamous epithelium, a 
cell type which is not the prime target of CF disease severity.  
 
Based on its location mCLCA5 is therefore unlikely to be a key player in the CF 
disease complex. 
 
For mCLCA6, a role in transepithelial ion conduction is conceivable in enterocytes 
either as part of a more complex channel structure or as a modulator of other 
channel proteins (Bothe et al. 2008). Predominant expression of mCLCA6 at small 
intestinal villous tips may suggest a role in absorptive processes that typically take 
place in these locations. mRNA localization in the barrier cells of the intestine and 
taking into account that CLCA have electrophysiological characteristics of CaCC 
(Gandhi et al. 1998; Gruber et al. 1998b; Gruber and Pauli 1999) may suggest a role 
in the CF disease complex. Furthermore, mRNA expression could be corroborated 
on protein level by our group (Bothe et al. 2008).  
Alternatively, a role as adhesion factor or in control of apoptosis and thus tumor 
growth inhibition as discussed previously cannot be entirely excluded (Abdel-Ghany 
et al. 2001; Elble and Pauli 2001). 
 
4.3 Extrapolation from Mouse to Human 
The diverging expression patterns of mCLCA5 to its human ortholog hCLCA2, and of 
mCLCA6 to its human ortholog hCLCA4 (Ritzka et al. 2003) could indicate the 
evolution of different functions of these proteins. For example, hCLCA2 was found to 
be the most abundant Cl- channel in corneal epithelium of the eye possibly 
contributing to corneal transparency (Itoh et al. 2000) whereas mCLCA5 was only 
expressed on mRNA level in the cornea. As further example, in addition to its 
intestinal expression, hCLCA4 is also expressed in brain, trachea uterus, salivary 
gland and mammary gland (Agnel et al. 1999), whereas mCLCA6 mRNA was 
exclusively expressed in the intestine (Bothe et al. 2008).  
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Although the coding sequences of the CLCA proteins are well conserved between 
the species, the respective non-coding regulatory sequences were subject to 
species-specific evolutionary change which may have led to functionally altered 
proteins (Ritzka et al. 2003). Moreover, different functional properties have been 
reported for direct orthologs of different species (Gruber et al. 1998a; Loewen et al. 
2004). Therefore, in human tissues the orthologs may still succumb to different 
transcriptional regulation. None the less, considering the expression pattern of the 
two murine CLCA family members mCLCA5 and mCLCA6, mCLCA6 is more likely to 
play a role in CF than mCLCA5. 
 
4.4 Quantitative mRNA Expression Comparison of Candidate CaCCs 
To further investigate whether mCLCA5, mCLCA6, the remaining mCLCA family 
members mCLCA1 to -4, the potential alternative mediators of a CaCC (mBEST1, 
mBEST2, mCLC-3B, mCLC-4, mTTYH3, mTMEM16A, mTMEM16F, mTMEM16K) 
and SLC26A9 are differentially regulated between murine wild type and CF tissues, 
quantitative mRNA expression analyses were carried out. Differential expression 
could suggest a role in the complex of CF on transcriptional level.  
The expression levels between the candidates themselves varied. mCLCA4, 
mTTYH3, mTMEM16A, mCLC-3B and mCLCA3 generally had highest mean value 
expression levels in the tissues tested. mCLCA5, mBEST1 and mCLCA1 had 
consistently minimal relative mRNA copy numbers.  
 
4.4.1 Comparison of the Expression Levels between the Wild Type and cftr 
Mutant Mouse Strains 
Of the six mCLCA family members, mCLCA6 had statistically significant higher 
expression levels in the caecum of the cftrTgH(neoim)Hgu model on the DBA/2 
background (Attachments: Figure 5) but not in any further intestinal segment tested 
nor in any other mouse model including the cftrtm1Cam model exhibiting the severe 
intestinal phenotype. This supports the notion that mCLCA6 may be involved in the 
complex CF pathology in the caecum. An up-regulation in the mouse model with the 
mild intestinal phenotype but not in the mouse model with the severe intestinal 
phenotype may suggest a role in amelioration of disease severity or for a link to the 
cftrTgH(neoim)Hgu genotype. 
mCLCA5 was not differentially regulated between the wild type and the cftr mutant 
mouse strains. Thus, not only the cellular localization in keratinocytes but also 
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quantitative expression analyses in CF relevant tissues argue against a role in the 
CF pathology. 
mCLCA3 had statistically significant higher expression levels in the stomach of the 
cftrTgH(neoim)Hgu model on the DBA/2 background (Attachments: Figure 5). 
Of all nine non-CLCA candidate genes tested, mTTYH3 mRNA had a strong and 
consistent differential expression on transcriptional level between the wild type NMRI 
and the CF mouse model cftrtm1Cam throughout the intestinal tract. Both in the small 
and large intestinal segments mTTYH3 mRNA was down-regulated. Of note, no 
down-regulation was observed in the cftrTgH(neoim)Hgu model exhibiting the milder 
intestinal disease phenotype. This suggests that mTTYH3 may be involved in the 
complex CF pathology. However, its down-regulation does not support the 
hypothesis of an alternative mediator of CaCC in the absence of cftr, at least not on 
transcriptional level.  
All other candidate genes had only sporadically differential expression levels in select 
tissues especially when expressed in only minute copy numbers and without 
recognizable consistency (see also Attachments: Figures 5 and 6). This suggests 
that they are not differentially regulated on transcriptional level. CF disease 
modulation is therefore unlikely to be caused by an up- or down-regulation of 
mCLCA1, -2, -4, -5, mBEST1, mBEST2, mCLC-3B, mCLC-4, mTMEM16A, 
mTMEM16F or mTMEM16K on transcriptional level. 
 
Thus, with the exception of mCLCA6 and mTTYH3 our results failed to identify 
consistently increased or decreased mRNA levels as evidence of transcriptional 
regulation or modulatory significance in CF tissues. Nevertheless, their proposed 
modulatory roles could still be based on posttranscriptional protein modification or 
functional regulation that have to be addressed in the future by other methodological 
approaches. 
Quantitative mRNA expression levels are frequently insufficient to predict protein 
expression levels, both of which are of critical importance to assess functional 
significance in a biological system (Gygi et al. 1999). Furthermore, 20-30% of all 
human genes are regulated on post-transcriptional level by micro RNAs (miRNAs), 
which influence mRNA cleavage or protein synthesis (Landi et al. 2008). 
Although mRNA of the candidate genes was detected in tissues relevant to CF, 
neither the presence nor the quantity of mRNA provide information of whether a 
translation will take place and if so whether a functional protein product will be 




For mCLCA6, the mRNA expression pattern was corroborated in wild type mice on 
protein level by work done in our group (Bothe et al. 2008) supporting its significance 
in the intestine, specifically in enterocytes. However, quantitative mRNA expression 
data frequently lack concordance with protein concentrations found in tissues (Gygi 
et al. 1999). Therefore, mCLCA6 may be differentially expressed between wild type 
and CF tissues on protein level. Semi-quantitative protein expression analyses for 
mCLCA3 for example revealed high protein expression levels compared to low 
mRNA expression levels in NMRI tissues (Leverkoehne et al. 2006), again revealing 
a discrepancy between both products. Therefore, it is not possible to conclude about 
the amount of protein based on copy numbers of mRNA. 
 
4.4.2 Comparison of the Expression Levels between the Four Wild Type 
Mouse Strains of Different Genetic Background: NMRI, BALB/c, DBA/2 
and C57BL/5 
The expression levels of the candidate genes were compared between the four 
genetic backgrounds to identify potential strain influences. Comparison of the 
expression levels of all 15 candidates between the BALB/c and NMRI wild type 
strains revealed significant and consistent but reciprocal expressional differences in 
the intestinal tract and liver for mTMEM16A and mBEST1. mTMEM16A had an 
approximately 10-fold higher expression in the BALB/c strain whereas mBEST1 had 
an approximately 4-fold higher expression in the NMRI strain. There were 
significantly higher expression levels in the BALB/c strain compared the NMRI strain 
for mCLC-3B in the jejunum, 8-fold, and caecum, 16-fold, for mTMEM16F in the 
colon, 5-fold, and for mTMEM16K in the stomach, 4-fold, and caecum, 10-fold.  
Additional genetic effects therefore seem to have an effect on the transcriptional 
regulation of these two genes. All other candidates tested had no significant 
differences in expression between the NMRI and BALB/c wild type strains.  
 
Data analyzing the comparison of the expression levels of mCLCA1, -2, -3, -4 and -6 
between all four wild type strains are included as attachment.  
They additionally revealed that mCLCA3 had overall strongest mean-value mRNA 
expression in the C57BL/6 strain. In the stomach this reached statistical significance 
to the DBA/2 and NMRI strains. mCLCA6 had overall weakest mean-value mRNA 
expression in the DBA/2 strain. In the caecum this reached statistical significance to 
the C57BL/6 and BALB/c strains (Attachments: Figure 3).  
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Overall, when viewing the strains in regard to their mCLCA expression, the DBA/2 
strain had weakest expression of mCLCA1, -3 and -6 in almost all tissues tested, 
reaching statistical significance to the C57BL/6 or BALB/c strains in the stomach 
(mCLCA3), caecum (mCLCA6), colon (mCLCA1, mCLCA3) and lungs (mCLCA1). 
Other way around, individual mCLCA members were not predominantly expressed in 
one of the four mouse strains. Therefore, again additional genetic effects may be 
involved influencing the expression of the mCLCA gene products, however, only 
sporadically reaching statistical significance. 
Taken together, these results suggest that the genetic background of the mice had 
an influence on the expression of select candidate genes, especially mTMEM16A 
and mBEST1. Strain specific differences in mRNA copy numbers have already been 
observed for CFTR (Ulatowski et al. 2004) and for members of the CLCA gene family 
(Leverkoehne et al. 2006). On the other hand, there is no evidence of the 
cftrTgH(neoim)Hgu mutation itself having different effects on the mRNA expression 
dependent on the genetic background it was inbred on, at least not for the five 
mCLCA family members tested in the C57BL/6, DBA/2 and BALB/c strains in the 
tissues analyzed.  
 
4.4.3 Comparison of the Expression Levels between the Two cftr Mutant 
Mouse Models: cftrTgH(neoim)Hgu  and cftrtm1Cam 
The expression levels between both mouse models were compared to identify a 
potential link between the type of cftr mutation and mRNA expression of the CaCC 
candidate. Statistically significant and consistent expressional differences were noted 
for mTTYH3 in the small and large intestine. The cftrtm1Cam model had up to 125-fold 
reduced mean mRNA expression compared to the cftrTgH(neoim)Hgu model. Although 
both models have different genetic backgrounds (BALB/c and NMRI for cftrTgH(neoim)Hgu  
and cftrtm1Cam, respectively) the expression of mTTYH3 mRNA in their wild type 
controls did not differ. This suggests that the down-regulation of mTTYH3 in the 





4.4.4 Comparison of the Expression Levels between the Three cftrTgH(neoim)Hgu 
Mutant Mouse Strains of Different Genetic Background: BALB/c, DBA/2 
and C57BL/5 
The three mouse strains BALB/c, DBA/2 and C57BL/6 were compared in order to 
analyze whether the strain specific expressional differences in the wild type mice 
were mirrored in their respective cftr mutant counterparts. The results are added as 
attachments (Attachments: Figure 4).  
 
Only the higher expression of mCLCA1 mRNA in the lungs of the C57BL/6 CF mice 
compared to the DBA/2 CF strain matched the difference between the respective 
wild type strains in terms of statistical significance. Nevertheless, most mean value 
differences at least had the same tendency between the CF matched and wild type 
matched strains. For example, mCLCA3 had a strong expression in the stomach of 
the C57BL/6 CF strain and mCLCA6 had weak expression in the caecum of the 
DBA/2 CF strain similar as was reported in the wild type counterparts above, yet 
neither reached statistical significance to the other strains. Other way around, 
mCLCA1 had weakest expression in the caecum, colon and lung of the DBA/2 CF 
strain with a significant difference to the C57BL/6 strain of which only the same 
tendency was mirrored in the wild type strain comparison. 
 
Otherwise, only sporadically different expression levels without recognizable 
consistency were noted between the four wild type strains, between the two CF 
models and between the three cftrTgH(neoim)Hgu mutant strains. Therefore, the genetic 
background did not have an obvious different effect on the expression of the mCLCA 
family members dependent on the cftr genotype. 
 
4.4.5 Comparison of Results with Previous Studies 
Interestingly, in a previous study jejunum had an increased mRNA copy number of 
mCLCA3 in BALB/c cftrTgH(neoim)Hgu and NMRI cftrtm1Cam mouse models (Leverkoehne 
et al. 2006). Up-regulation of mCLCA3 was explained by an elevated number of 
mCLCA3 expressing goblet cells as observed in the intestine of most murine CF 
models (Grubb and Boucher 1999). In another study, mCLCA3 was significantly 
reduced in the intestine of cftrtm1Unc mice on a C57BL/6 background although the 
number of goblet cells was elevated (Young et al. 2007). In this study, mCLCA3 had 
up-regulated expression in the stomach of the cftrTgH(neoim)Hgu model on the DBA/2 
background but not in any other tissues tested including the intestine and not in the 
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cftrtm1Cam model. Differences in expression could be due to the different genetic 
backgrounds of the mice. In the case of contradictory expression levels between 
mice with the same genetic background factors including different housing 
conditions, environmental influences, nutrition and sample handling can not be 
excluded as having an effect on the expression levels of CLCA. Due to these 
contradictory results the significance of this finding and the evaluation of mCLCA3 as 
a modulator of the CF phenotype needs further investigations.  
mCLCA2 on the other hand was hypothesized to be transcriptionally up-regulated in 
the jejunum of the cftrTgH(neoim)Hgu mice on the BALB/c background (Leverkoehne et al. 
2006). In this study mCLCA2 was not differentially expressed in the intestine. 
However, both in this study and in the same sized groups of mice in the study by 
Leverkoehne (Leverkoehne et al. 2006) mRNA copy numbers of individual mice of 
the same group varied greatly. Most groups of five mice had at least one outlier or 
extreme value. These variations may conceal detection of statistically significant 
differences in small groups of mice. Small study populations have already led to 
conflicting results in the past (Buscher and Grasemann 2006).  
 
For mCLCA5, a broader yet overlapping mRNA expression pattern was detected 
compared to immunohistochemical protein staining results carried out by our group. 
An arbitrary threshold of approximately 0.3 relative mCLCA5 copies separated 
tissues in which protein staining was detected (> 0.3 relative copies, except for the 
eye) from tissues with negative staining results (< 0.3 relative copies, except for the 
thymus). The observation that not all mRNA is translated into a protein could be due 
to differences in mRNA stability by post-transcriptional modifications or epigenetic 
effects on translation. Specific miRNA or small interfering RNA (siRNA) could also 
bind to the mRNA and increase or decrease their activity and prevent a protein 
product from being produced. 
 
4.5 Do the Candidate Genes Play a Role in CF? 
mCLCA6 and mCLCA3 were transcriptionally up-regulated in the caecum and the 
stomach of the cftrTgH(neoim)Hgu DBA/2 mice, respectively, whereas mTTYH3 was 
transcriptionally down-regulated throughout the intestine of the cftrtm1Cam NMRI mice. 
At least on transcriptional level both mCLCA6 and mCLCA3 may have a positive 
“alternative” modulatory effect on CaCC whereas mTTYH3 is more likely to have a 
negative modulatory effect, decreasing CaCC.  
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The hypothesis that the CF mice lack CF like pulmonary disease and pancreas 
insufficiency as a consequence of transcriptional overexpression of the candidate 
genes tested here cannot be supported. However, the gene products may be 
regulated on post-transcriptional level evoking a modulatory function which is 
disguised when characterized by relative quantification of mRNA levels.  
 
Based on their cellular localization and quantitative expression analyses, mCLCA6 is 
more likely to be involved in the pathophysiological mechanisms associated with CF 
than mCLCA5. Similar to several CLCA proteins, both mCLCA6 and mCLCA5 have 
been reported to evoke a Ca2+-activated Cl- conductance when heterologously 
transfected into HEK293 cells (Evans et al. 2004). Due to their different cellular 
localizations, different functional properties were discussed.  
The localization of mCLCA6 mRNA in the intestine could point towards a potential 
role in modulating Cl- secretion in the absence of functional CFTR in this localization. 
Differential expression on transcriptional level in the caecum supports enhanced 
functional properties of the gene product in the absence of CFTR and the potential to 
modulate other ion channel proteins similar as described for pCLCA1 (Hamann et al. 
2009; Loewen et al. 2002) which subsequently could modulate disease severity. The 
colocalization of mCLCA6 with CFTR, as described in (Bothe et al. 2008), further 
supports the potential modulatory role of mCLCA6. 
mCLCA5, on the other hand, was immune electron microscopically localized to 
stratified squamous epithelium which is not a prime target of CF disease and thus 
does not primarily point toward a potential role in modulating disease severity. 
 
Based on differential mRNA expression, mTTYH3 may be involved in the complex 
CF pathology of the intestine. mTTYH3 mRNA was markedly down-regulated 
throughout the intestine of the cftrtm1Cam mouse model with the complete functional 
CFTR knockout and the severe phenotype but not in the cftrTgH(neoim)Hgu mouse model 
exhibiting residual CFTR Cl- conductance and a milder intestinal phenotype. This 
suggests an association between the more severe intestinal phenotype and lack of 
mTTYH3 expression. The results argue against a direct compensatory action in the 
sense of an alternative anion conductance observed in CF epithelia (Clarke et al. 
1994; Wilschanski et al. 1996). mTTYH3 is also unlikely to account for the CaCC 
conductance inhibited by CFTR or activated by defective CFTR (Kunzelmann et al. 
1997b; Wei et al. 1999). On the contrary, the complete absence of functional CFTR 
may indirectly inhibit expression of mTTYH3. A lack or potential down-regulation of 
mTTYH3 expression may even exacerbate disease severity. On the other hand, it 
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would be interesting to investigate whether an up-regulation or enhancement of 
mTTYH3 expression changes intestinal phenotype, possibly reversing the process. 
 
Taken together, the results of this project indicate that of all 15 candidates tested that 
possibly could modify disease severity based on their similar electrophysiological 
characteristics to CaCC and/or their tissue expression pattern, mCLCA6, mCLCA3 
and mTTYH3 may play a role in CF as far as can be judged from the quantitative 
cellular RNA expression pattern analyses in CF mice. All candidates could, however, 
also be regulated on the functional or protein expressional level. 
 
4.6 Conclusion 
The two murine CLCA family members mCLCA5 and mCLCA6 have their own 
distinct cellular mRNA expression pattern. mCLCA5 mRNA had a broad expression 
pattern with elevated levels in tissues containing stratified squamous epithelia. 
mCLCA5 protein was immune electron microscopically localized to cytoplasmic 
granules of granular layer keratinocytes of stratified squamous epithelia. This 
suggests a role in cornification and thus barrier function. It does not support a 
potential role in CF. mCLCA6 mRNA was exclusively expressed in enterocytes 
suggesting a role in modulating transepithelial ion conductance and thus fluid 
secretion. Furthermore, it was up-regulated in the caecum of the cftrTgH(neoim)Hgu 
DBA/2 mice with the mild disease phenotype further supporting a potential 
modulatory role in CF as part of an alternative CaCC pathway.  
 
For mTTYH3 a significant and consistent down-regulation in the intestine of the 
cftrtm1Cam mouse model compared to the wild type NMRI control was detected. This 
suggests a modulatory role of mTTYH3 in the pathogenesis of the severe intestinal 
CF phenotype most likely contributing to diminished CaCC. Only few sporadic and 
inconsistent significant differences were observed for the remaining candidates 
tested. 
These investigations neither confirm nor reject the other candidate genes mCLCA1,  
-2, -4, -5, mBEST1, mBEST2, mCLC-3B, mCLC-4, mTMEM16A, mTMEM16F, 
mTMEM16K of SLC26A9 exerting modulatory functions. Thus, further investigations 
are necessary, especially on protein and functional levels in order to evaluate their 





In order to further assess the 15 candidates selected in this study as putative targets 
for CF disease intervention their functional niches and interacting molecules need to 
be clarified for further integration into the complexity of disease mechanisms. 
To date, a number of genes modifying tissue specific CF disease severity have been 
identified (Cutting 2005). Some, for example TGFB1 (Transforming Growth Factor 
Beta 1), are associated with worse pulmonary outcome (Dorfman et al. 2008). 
Others, for example IFRD1 (Interferon-Related Developmental Regulator 1), 
modulate disease severity by regulating the inflammatory response in the lungs (Gu 
et al. 2009). In lungs, genes affecting inflammation play a key role in modulating 
disease severity (Collaco and Cutting 2008). Based on these observations, an 
interesting question to pursue is whether the candidates mCLC-3B, mCLC-4, 
mTTYH3, mTMEM16A, mTMEM16F and mTMEM16K expressed in the lung may 
stimulate increased Cl- conductance after “activation” by inflammatory factors or by 
increased Ca2+ levels due to the inflammatory response secondary to the cftr gene-
defect. For example, the cytokine IL-4 (interleukin-4), a mediator of inflammation, 
causes an increase in Ca2+-dependent Cl- channel activity (Caputo et al. 2008). Thus, 
the inflammatory response, which is frequently a sequel to defective Cl- conductance 
in CF, could modulate the candidate proteins expressed in the lung.  
Dependent on the tissue, variability of the CF phenotype is more or less correlated 
with the CFTR genotype. For example, exocrine pancreas insufficiency is closely 
correlated with the CFTR genotype whereas lung disease is poorly correlated with 
the CFTR genotype (Cutting 2005). Intestinal disease severity is also strongly 
influenced by modifier genes (Cutting 2005) and mTTYH3 may be a negative 
modifier of the intestinal physiology in mice. A similar correlation is in fact 
demonstrated for ENaC (epithelial sodium channel). Absent ENaC inhibition impairs 
lung function in mice due to deficient cftr (Mall 2009). 
Besides a Cl- channel function of CFTR, its regulatory functions on other proteins are 
also important in regulating CF pathophysiology (Duran et al. 2009). CFTR is known 
to regulate channels and transporters including SLC26A3, a HCO3
- transporter 
(Duran et al. 2009), ENaC (Mall et al. 2004), which is down-regulated by CFTR in 
respiratory epithelium (Grubb et al. 1994; Kunzelmann et al. 1997a), and volume-
regulated anion channel VRAC (Vennekens et al. 1999). HCO3
- secretion is 
important to CF pathology and is permeant through bestrophin channels (Qu and 
Hartzell 2008). Furthermore, Wei and coworkers concluded in their studies that 
CFTR and CaCC functionally interact and that CFTR reduces endogenous CaCC 
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currents (Wei et al. 1999). On the other hand, expression of defective CFTR could 
up-regulate CaCC channels (Kunzelmann et al. 1997b). The opposite seems to be 
true for mTTYH3 in the latter scenario. Reduced mTTYH3 expression in the cftrtm1Cam 
model may be a direct consequence of lack of CFTR expression, possibly in terms of 
lack of activation by functional CFTR. 
Electrophysiological interactions between CFTR and mTTYH3 could help clarify 
whether CFTR modulates the expression of mTTYH3 or whether other factors are 
involved. To investigate if the transcriptional down-regulation has a negative effect on 
the intestinal phenotype, histopathological examinations of cftrtm1Cam mutant mice with 
over expression of mTTYH3 would be interesting. 
The human orthologs of the two candidate gene products mBEST1 and mTMEM16A 
have been described to functionally interact. TMEM16A is activated by the Ca2+ 
signaling generated by BEST1 (Barro-Soria et al. 2009). It is therefore possible that 
in the mouse models used here mTMEM16A consistently had higher mean value 
relative copy numbers of mRNA compared to mBEST1 in all of the tissues tested due 
to enhanced specific Ca2+ signaling. It would therefore be interesting to test the 
difference in expression of mTMEM16A between wild type and mBEST1 knockout 
mice. 
 
On transcriptional level, quantitative analyses of miRNAs for each candidate could 
reveal clues about whether these genes are regulated independently of the cftr 
genotype prior to translation (Cronin et al. 2004). miRNAs are a small class of 
noncoding RNA molecules, likely encoded by introns, which play a regulatory role in 
post-transcriptional gene regulation. They have for example been described to have 
an inhibitory effect on translation and cause mRNA destabilization, reviewed in 
(Bushati and Cohen 2007).  
A comparative DNA chip analysis between wild type and CF tissues could then again 
confirm and/or uncover additional candidate modifier genes on the transcriptional 
regulatory level. 
 
On post transcriptional level, quantitative protein and functional analyses of the 
candidates would be interesting in order to analyze in how far the mRNA expression 
levels and differences correlate with the protein expression levels.  
 
Finally, similar expression analyses as carried out in the mouse models could be 
carried out in the recently developed pig models of CF, which resemble the human 
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more closely in physiology, size, genetics and CF phenotype (Rogers et al. 2008a; 
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5. Summary 
 
Candidates for Alternative Chloride Conductance in Cystic Fibrosis: 
Localization of mCLCA5 and mCLCA6 and Quantitative mRNA Expression 
Analyses of 15 Candidate Genes 
Josephine Braun 
 
Cystic Fibrosis (CF) is a fatal autosomal recessive inherited genetic disease in 
humans caused by mutations in the cystic fibrosis transmembrane conductance 
regulator (CFTR) gene. CFTR encodes for a Cl- channel in secretory epithelia. Its 
absence or malfunction lead to altered regulation of Cl- secretion across epithelial 
membranes and a phenotype of severe pulmonary disease, pancreatic insufficiency, 
meconium ileus in newborns and other conditions.  
Interestingly, the CF phenotype has large variations. Even dizygous twins sharing 
most environmental influences show clinical variations. This suggests that factors 
other than CFTR modulate disease severity. One of these factors is a CFTR-
independent, Ca2+-activated Cl- current (CaCC) which was demonstrated to 
ameliorate disease severity in the intestine, lungs and pancreas of CF mouse models 
and in part in humans. The molecules responsible for these CaCC may be potential 
therapeutical targets. However, its molecular identity is still unknown.  
First aim of the study was to investigate the tissue specific and cellular mRNA 
expression pattern of two new murine CLCA family members (mCLCA5 and 
mCLCA6) as important prerequisite for protein and functional analyses. Second aim 
was to characterize the cellular mRNA expression levels of select CaCC candidates 
and modulators and possibly transcriptional regulatory changes under conditions of 
CF.  
This study used laser capture microdissection (LCM) and immune electron 
microscopy to determine cellular localizations of mCLCA5 and mCLCA6. It used 
reverse transcriptase quantitative polymerase chain reaction (RT-qPCR) to quantify 
and compare the mRNA expression of 15 candidate modulators of CaCC in tissues 
relevant to CF (stomach, duodenum, jejunum, caecum, colon, pancreas, liver, lung, 
kidney) between two different CF mouse models and their wild type controls. One 
mouse model (cftrTgH(neoim)Hgu on BALB/c, DBA/2 and C57BL/6 backgrounds) exhibits 
residual cftr and a milder phenotype than the other mouse model (cftrtm1Cam on NMRI 
background) with the complete cftr knockout.  
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Candidates tested were the Ca2+-activated Cl- channels mBEST1, mBEST2, 
mTTYH3, mTMEM16A, mTMEM16F, mTMEM16K, the Ca2+-activated Cl- 
transporters mCLC-3B and mCLC-4, as well as six murine CLCA gene family 
members (mCLCA1 to -6), which encode proteins that evoke Ca2+-activated Cl-  
currents but do not form channels themselves. Additionally the Cl- channel SLC26A9 
was tested.  
Similar to their homologs and orthologs within the CLCA gene family, mCLCA5 and 
mCLCA6 had their own distinct cellular localizations. mCLCA5 mRNA had a broad 
expression pattern whereas the protein was found exclusively in cytoplasmic 
granules of granular layer keratinocytes of stratified squamous epithelia suggesting a 
role in cornification and an inferior relevance in CF. mCLCA6 mRNA was exclusively 
expressed in enterocytes suggesting a role in transepithelial anion conductance and 
fluid secretion which may be of relevance in CF.  
Of all investigated candidates, only mCLCA6 and mCLCA3 were up-regulated in the 
caecum and stomach of the cftrTgH(neoim)Hgu DBA/2 mice respectively and only the 
tweety Cl- channel mTTYH3 was markedly down-regulated throughout the intestinal 
tract of the cftrtm1Cam NMRI mice. This supports mCLCA6 and mCLCA3 as potential 
mediators of “alternative” CaCC in CF but argues against a direct compensatory 
mechanism on transcriptional level in the lungs, pancreas or intestine. On the 
contrary, mTTYH3 may be linked to the more severe intestinal phenotype suggesting 
a negative modulatory effect. However, it cannot be excluded that any of the 
candidates tested are regulated on post-transcriptional level or by modulation of the 
protein activation status. Thus they may still play a role as modulators in the basic Cl- 
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6. Zusammenfassung 
 
Kandidaten der alternativen Chloridleitfähigkeit bei Zystischer Fibrose: 
Lokalisierung von mCLCA5 und mCLCA6 und quantitative mRNA 
Expressionsanalysen von 15 Kandidatengenen 
Josephine Braun 
 
Zystische Fibrose (englisch cystic fibrosis, CF) ist eine tödlich verlaufende, autoso-
mal rezessiv vererbte Erkrankung, die durch Mutationen des CFTR-Gens verursacht 
wird. CFTR codiert für einen Chloridkanal in sekretorischen Epithelien, dessen Feh-
len oder Defekt eine fehlregulierte Chloridströmung und schwerwiegende Lungener-
krankungen, Pankreasinsuffizienz sowie Mekoniumileus bei Neugeborenen hervor-
rufen kann. 
Interessanterweise zeigen dizygote Zwillinge, die den identischen CFTR-Defekt tra-
gen und unter gleichen Umweltbedingungen leben, eine hohe klinische und patholo-
gische Variation des CF-Phänotyps. Über den CFTR-Gendefekt hinausgehende ge-
netische Faktoren scheinen den Schweregrad der Erkrankung zu beeinflussen. Zu 
diesen sogenannten modifier genes gehört eine CFTR-unabhängige, Ca2+-aktivierte 
Chloridleitfähigkeit (CaCC), die den Darm-, Lungen- und Pankreas-Phänotyp in CF-
Mausmodellen mildert und sich möglicherweise als therapeutisches Ziel eignet. Lei-
der ist deren molekulare Identität und Modulation bislang jedoch ungeklärt.  
Erstes Ziel der Studie war es, das bislang unbekannte gewebsspezifische und zellu-
läre mRNA-Expressionsmuster von zwei murinen CLCA Vertretern (mCLCA5 und 
mCLCA6) zu bestimmen. Zweites Ziel war es die zellulären mRNA Expressionshö-
hen ausgewählter CaCC-Kandidaten und Modulatoren zu analysieren sowie mögli-
che regulatorische Veränderungen auf transkriptioneller Ebene unter CF Bedingun-
gen festzustellen.  
Diese Studie hat mittels Lasermikrodissektion und Immunelektronenmikroskopie die 
zelluläre Lokalisation von mCLCA5 und mCLCA6 bestimmt. Sie quantifiziert und ver-
gleicht mithilfe der Reversen Transkriptase quantitativen Polymerasekettenreaktion 
(RT-qPCR) die mRNA-Expression von 14 Vertretern, die potenzielle CaCC-Kandi-
daten oder -Modulatoren darstellen, in CF-relevanten Geweben (Magen, Duodenum, 
Jejunum, Zäkum, Kolon, Pankreas, Leber, Lunge, Niere) zwischen zwei verschiede-
nen CF-Mausmodellen und deren Wildtyp-Kontrollen. Eines der hier untersuchten 
Mausmodelle (cftrTgH(neoim)Hgu auf BALB/c, DBA/2 und C57BL/6 Hintergründen) zeigt 
eine residuelle cftr-Aktivität und einen milderen Phänotyp, während das andere 
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Mausmodel (cftrtm1Cam auf NMRI Hintergrund) einen kompletten cftr-Knockout dar-
stellt und einen schwereren Phänotyp zeigt. 
In den Mausmodellen wurden die Ca2+-aktivierten Chloridkanäle mBEST1, mBEST2, 
mTTYH3, mTMEM16A, mTMEM16F, mTMEM16K und die Ca2+-aktivierten Chlorid-
transporter mCLC-3B und mCLC-4 untersucht. Des Weiteren wurden sechs Mitglie-
der der CLCA Genfamilie (mCLCA1 bis -6) analysiert, die selbst keine Kanalproteine 
sind, jedoch Ca2+-aktivierte Chloridströme hervorrufen können. Zusätzlich wurde der 
Chloridkanal SLC26A9 untersucht.  
mCLCA5 und mCLCA6 zeigten, ähnlich wie ihre Homologen und Orthologen, jeweils 
spezifische zelluläre Lokalisationen. mCLCA5 mRNA zeigte ein weites Expressions-
muster, wobei das Protein nur in zytoplasmatischen Granula der Keratinozyten des 
Stratum granulosum aller Plattenepithelien gefunden wurde, was auf eine Funktion in 
der Verhornung vermuten lässt, und für CF eine untergeordnete Rolle zu spielen 
scheint. mCLCA6-mRNA wurde ausschließlich in Enterozyten gefunden. Diese 
Lokalisation deutet auf eine Funktion bei der transepithelialen Anionenströmung hin, 
welche für CF von hoher Relevanz sein könnte.  
Von allen untersuchten Kandidaten waren nur mCLCA6 und mCLCA3 im Zäkum 
bzw. Magen der cftrTgH(neoim)Hgu DBA/2-Mäuse hochreguliert, wohingegen der Tweety-
Chloridkanal mTTYH3 im gesamten Darmtrakt der cftrtm1Cam NMRI-Mäuse herunter-
reguliert war.  
Diese Ergebnisse sprechen dafür, dass mCLCA6 und mCLCA3 Mediatoren der 
„alternativen“ CaCC in CF sein könnten, sprechen jedoch gegen einen direkten kom-
pensatorischen Mechanismus auf transkriptioneller Ebene in Lunge, Pankreas oder 
Darm, mTTYH3 könnte dagegen sogar mit einem schwerwiegenderen intestinalen 
Phänotyp im Zusammenhang stehen. Es kann jedoch nicht ausgeschlossen werden, 
dass einer oder mehrere der anderen untersuchten Kandidaten auf post-transkrip-
tioneller Ebene oder durch Modulation des Proteinaktivierungsstatus reguliert wird 
und daher trotzdem als Modulator im Erkrankungskomplex CF eine Rolle spielt. 
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8. Talks and Poster 
 
Talks: 
• 2nd European CF Young Investigator Meeting (EYIM) in Lille, France (2008) 
Differential expression of murine CLCA-gene family members in cystic 
fibrosis mouse models. 
• 7th Project Supervisor Meeting of the Mukoviszidose e.V. at Schloss Mickeln, 




• 2nd European CF Young Investigator Meeting (EYIM) in Lille, France (2008) 
Differential expression of murine CLCA-gene family members in cystic 
fibrosis mouse models. 
• 10th German Mucoviscidosis Congress in Würzburg, Germany (2007) 
Differentielle Expressionsanalysen von Clca-Genen bei zystischer Fibrose.
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9. Attachments 
 
9.1 Quantification of mCLCA6 and mCLCA3 in Luminal and Basal Crypt 
Epithelial Cells of the Caecum  
mCLCA6 and mCLCA3 mRNA were quantified in approximately 3 million µm2 luminal 
and basal crypt epithelial cells of the caecum following laser capture microdissection. 
The caecum of one C57BL/6 10-week-old mouse was used. Killing of the mouse, 
tissue processing, laser capture microdissection, RNA isolation, reverse 
transcription, real-time quantitative polymerase chain reaction, quantification of target 
gene expression and statistical analyses were carried out according to the same 
procedures as described in the materials and methods section of the manuscript 
Bothe et al 2008. 
The results of these data were presented and discussed in the discussion and are 
depicted in figure 2. 
 
Figure 2:  
Predominant expression of mCLCA6 and mCLCA3 in luminal epithelial cells of the caecum of the C57BL/6 strain 
Laser capture microdissection was used to isolate approximately three million µm2 of luminally located and basally 
located enterocytes of the caecum crypts prior to RT-qPCR. mCLCA6 had higher relative copy numbers in the 
luminal compared to the basal crypt epithelial cells and was more abundantly expressed in the luminal crypt epithelial 





9.2 Relative Quantification of mCLCA1, -2, -3, -4 and -6 in the cftrTgH(neoim)Hgu 
Mouse Model Inbred on C57BL/6 and DBA/2, BALB/c and NMRI Genetic 
Backgrounds and Their Respective Wild Types 
In addition to quantification in the BALB/c and NMRI strains, mCLCA1, mCLCA2, 
mCLCA3, mCLCA4 and mCLCA6 were also each quantified in the cftrTgH(neoim)Hgu 
mouse model inbred on C57BL/6 and DBA/2 backgrounds.  
Each group included five female 10-week-old mice. Killing of the mice, tissue 
processing, RNA isolation, reverse transcription, real-time quantitative polymerase 
chain reaction, quantification of target gene expression and statistical analyses were 
carried out according to the same procedures as described in the materials and 
methods section of the manuscript Braun et al 2009. 
The results of these data were presented and discussed in the discussion and are 
depicted in figures 3 to 6.  
 
Figure 3:  
Comparison of relative expression levels of mCLCA members between the four wild type strains 
For each organ analyzed the relative mRNA copy numbers of the genes of interest (GOI) for each of the four wild 
type strains are plotted: C57BL/6 (black columns), DBA/2 (dark grey columns), BALB/c (light grey columns) and 
NMRI (white columns). 
mCLCA3 had overall strongest mean-value mRNA expression in the C57BL/6 strain. In the stomach this reached 
statistical significance to the DBA/2 and NMRI strains. mCLCA6 had overall weakest mean-value mRNA expression 
in the DBA/2 strain. In the caecum this reached statistical significance to the C57BL/6 and BALB/c strains.  
Overall, when viewing the strains in regard to their mCLCA expression, the DBA/2 strain had weakest expression of 
mCLCA1, -3 and -6 in almost all tissues tested, reaching statistical significance to the C57BL/6 or BALB/c strains in 
the stomach (mCLCA3), caecum (mCLCA6), colon (mCLCA1, mCLCA3) and lungs (mCLCA1). Other way around, 
individual mCLCA members were not predominantly expressed in any of the four mouse strains. 
In all box plots, outliers are marked by circles, extreme values by asterisks. An outlier has a value of more than 1.5 
quartile spaces beyond the middle 50%. An extreme value is more than 3 quartile spaces beyond. A horizontal 
bracket with a hash marks a statistically significant difference between the wild type and CF groups. n = 5 mice per 






















Figure 4:  
Comparison of relative expression levels of mCLCA members between the four CF strains 
For each organ analyzed the relative mRNA copy numbers of the genes of interest (GOI) for each of the four CF 
strains are plotted: C57BL/6 cftrTgH(neoim)Hgu (black columns), DBA/2 cftrTgH(neoim)Hgu (dark grey columns), BALB/c 
cftrTgH(neoim)Hgu (light grey columns) and NMRI cftrtm1Cam (white columns). 
Only the higher expression of mCLCA1 mRNA in the lungs of the C57BL/6 CF mice compared to the DBA/2 CF 
strain matched the difference between the respective wild type strains in terms of statistical significance. 
Nevertheless, most mean value differences at least had the same tendency between the CF matched and wild type 
matched strains. For example, mCLCA3 had a strong expression in the stomach of the C57BL/6 CF strain and 
mCLCA6 had weak expression in the caecum of the DBA/2 CF strain similar as was reported in the wild type 
counterparts, yet neither reached statistical significance to the other strains. Other way around, mCLCA1 had 
weakest expression in the caecum, colon and lung of the DBA/2 CF strain with a significant difference to the C57BL/6 
strain of which only the same tendency was mirrored in the wild type strain comparison. 
In all box plots, outliers are marked by circles, extreme values by asterisks. An outlier has a value of more than 1.5 
quartile spaces beyond the middle 50%. An extreme value is more than 3 quartile spaces beyond. A horizontal 
bracket with a hash marks a statistically significant difference between the wild type and CF groups. n = 5 mice per 








Figure 5:  
Comparison of relative expression levels of mCLCA members between wild type and cftrTgH(neoim)Hgu mice on the 
DBA/2 background 
The relative mRNA copy numbers of mCLCA1, mCLCA2, mCLCA3, mCLCA4 and mCLCA6 are plotted for both the 
wild type (black columns) and CF (grey columns) tissues of the DBA/2 mice.  
mCLCA6 had statistically significant higher expression levels in the caecum and mCLCA3 had statistically significant 
higher expression levels in the stomach of the cftrTgH(neoim)Hgu model on the DBA/2 background.  
In all box plots, outliers are marked by circles, extreme values by asterisks. An outlier has a value of more than 1.5 
quartile spaces beyond the middle 50%. An extreme value is more than 3 quartile spaces beyond. A horizontal 
bracket with a hash marks a statistically significant difference between the wild type and CF groups. n = 5 mice per 







Figure 6:  
Comparison of relative expression levels of mCLCA members between wild type and cftrTgH(neoim)Hgu mice on the 
C57BL/6 background 
The relative mRNA copy numbers of mCLCA1, mCLCA2, mCLCA3, mCLCA4 and mCLCA6 are plotted for both the 
wild type (black columns) and CF (grey columns) tissues of the C57BL/6 mice.  
Only sporadically differential expression levels in select tissues were detected especially when the GOI was 
expressed in only minute copy numbers without recognizable consistency.  
In all box plots, outliers are marked by circles, extreme values by asterisks. An outlier has a value of more than 1.5 
quartile spaces beyond the middle 50%. An extreme value is more than 3 quartile spaces beyond. A horizontal 
bracket with a hash marks a statistically significant difference between the wild type and CF groups. n = 5 mice per 
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